Table 2.
Joinpoint regression analysis of liver cancer between 1990 and 2019 in China.
| Disease | Metric | Statistics | Period | Values |
|---|---|---|---|---|
| Total liver cancer | Incidence rates | APC | 1990–1999 | −0.2 (−0.6, 0.9) |
| APC | 1999–2006 | −13.7 (−14.9, −12.4) | ||
| APC | 2006–2019 | −0.4 (−0.1, 0.8) | ||
| AAPC | 1990–2019 | −3.3 (−3.7, −2.9) | ||
| Mortality rates | APC | 1990–1999 | 0.4 (−0.5, 1.3) | |
| APC | 1999–2005 | −15.7 (−17.6, −13.7) | ||
| APC | 2005–2019 | −0.8 (−1.3, −0.3) | ||
| AAPC | 1990–2019 | −3.7 (−4.3, −3.2) | ||
| DALYs rates | APC | 1990–1999 | −14.7 (−16.2, −13.1) | |
| APC | 1999–2006 | −0.1 (−0.6, 0.5) | ||
| APC | 2006–2019 | −3.9 (−4.4, −3.3) | ||
| AAPC | 1990–2019 | −3.8 (−5.5, −2.1) | ||
| Liver cancer attributable to HBV | Incidence rates | APC | 1990–1999 | 0.4 (−0.4, 1.2) |
| APC | 1999–2006 | −14.0 (−12.7, −21.1) | ||
| APC | 2006–2019 | 0.3 (−0.2, 0.7) | ||
| AAPC | 1990–2019 | −3.3 (−3.8, −2.9) | ||
| Mortality rates | APC | 1990–1999 | 0.7 (−0.2, 1.6) | |
| APC | 1999–2005 | −17.8 (−14.1, −16.5) | ||
| APC | 2005–2019 | −0.9 (−1.4, −0.5) | ||
| AAPC | 1990–2019 | −3.8 (−4.3, −3.3) | ||
| DALYs rates | APC | 1990–1999 | 0.4 (−0.6, 1.4) | |
| APC | 1999–2005 | −16.6 (−18.5, −14.5) | ||
| APC | 2005–2019 | −0.8 (−1.3, −0.3) | ||
| AAPC | 1990–2019 | −3.9 (−4.5, −3.4) | ||
| Liver cancer attributable to HCV | Incidence rates | APC | 1990–1999 | −0.5 (−1.2, 0.3) |
| APC | 1999–2006 | −13.0 (−14.2, −11.8) | ||
| APC | 2006–2019 | −0.1 (−0.5, 0.3) | ||
| AAPC | 1990–2019 | −3.5 (−3.9, −3.1) | ||
| Mortality rates | APC | 1990–1999 | −0.6 (−1.6, 0.4) | |
| APC | 1999–2006 | −13.3 (−14.9, −11.7) | ||
| APC | 2006–2019 | −0.6 (−1.6, 0.4) | ||
| AAPC | 1990–2019 | −3.8 (−4.4, −3.3) | ||
| DALYs rates | APC | 1990–1999 | −0.9 (−1.9, −0.2) | |
| APC | 1999–2006 | −14.0 (−15.7, −12.3) | ||
| APC | 2006–2019 | −0.5 (−1.1, 0.1) | ||
| AAPC | 1990–2019 | −4.0 (−4.6, −3.5) | ||
| Liver cancer attributable to alcohol use | Incidence rates | APC | 1990–1999 | −0.2 (−1.0, 0.6) |
| APC | 1999–2006 | −13.2 (−14.5, −11.9) | ||
| APC | 2006–2019 | 1.5 (1.1, 2.0) | ||
| AAPC | 1990–2019 | −2.8 (−3.2, −2.3) | ||
| Mortality rates | APC | 1990–1999 | −0.3 (−1.3, 0.7) | |
| APC | 1999–2006 | −13.5 (−15.1, −11.9) | ||
| APC | 2006–2019 | 1.0 (0.4, 1.6) | ||
| AAPC | 1990–2019 | −3.1 (−3.7, −2.6) | ||
| DALYs rates | APC | 1990–1999 | −0.7 (−1.7, 0.4) | |
| APC | 1999–2006 | −14.2 (−15.8, −12.5) | ||
| APC | 2006–2019 | 1.0 (0.4, 1.6) | ||
| AAPC | 1990–2019 | −3.4 (−4.0, −2.8) | ||
| Liver cancer attributable to NASH | Incidence rates | APC | 1990–2000 | −0.5 (−1.2, 0.1) |
| APC | 2000–2006 | −14.3 (−15.9, −12.7) | ||
| APC | 2006–2019 | 1.7 (1.3, 2.1) | ||
| AAPC | 1990–2019 | −2.6 (−3.0, −2.2) | ||
| Mortality rates | APC | 1990–1999 | 0.3 (−0.5, 1.2) | |
| APC | 1999–2006 | −13.3 (−14.7, −11.9) | ||
| APC | 2006–2019 | 1.1 (0.6, 1.6) | ||
| AAPC | 1990–2019 | −2.8 (−3.3, −2.4) | ||
| DALYs rates | APC | 1990–1999 | 0.1 (−0.8, 1.1) | |
| APC | 1999–2006 | −14.3 (−15.8, −12.8) | ||
| APC | 2006–2019 | 1.0 (0.5, 1.6) | ||
| AAPC | 1990–2019 | −3.2 (−3.7, −2.7) |
AAPC: the average annual percentage change; APC: the annual percentage change; DALYs: disability-adjusted life years; HBV: hepatitis B; HCV: hepatitis C.